Postmarketing Cases of Enfortumab Vedotin–Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis
Michelle Nadeau Nguyen, Melissa Reyes, S. Christopher Jones
Abstract
This case series study uses data from the FDA Adverse Event Reporting System to investigate a potential association between enfortumab vedotin treatment and Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Topics & Concepts
Toxic epidermal necrolysisMedicineDermatologyDrug reactionPharmacologyDrugDrug-Induced Adverse ReactionsAutoimmune Bullous Skin DiseasesNail Diseases and Treatments